According to Grifols's latest financial reports the company's current earnings (TTM) are $0.36 B. In 2020 the company made an earning of $1.02 B an increase over its 2019 earnings that were of $0.91 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.36 B | |
2020 | $1.02 B | 11.7% |
2019 | $0.91 B | 7.03% |
2018 | $0.85 B | 7.35% |
2017 | $0.79 B | 1.16% |
2016 | $0.78 B | 2.98% |
2015 | $0.76 B | -0.66% |
2014 | $0.76 B | 16.54% |
2013 | $0.65 B | 30.75% |
2012 | $0.50 B | 366.36% |
2011 | $0.10 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 4,565.76% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | 2,059.41% | ๐บ๐ธ USA |
Baxter BAX | -$47 M | -112.92% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $2.02 B | 455.59% | ๐บ๐ธ USA |